Human leukocyte antigen-haploidentical donor-derived cytokine-induced killer cells are safe and prolong the survival of patients with advanced non-small cell lung cancer

The aim of the present study was to evaluate the safety and efficacy of administering cytokine-induced killer cells (termed allogeneic CIKs), obtained from the blood of the offspring of patients, for the treatment of non-small cell lung cancer. Symptoms, signs and laboratory assessment results for 3...

Descripción completa

Detalles Bibliográficos
Autores principales: WANG, SHIYONG, ZHANG, HUI, LIU, CHANG, JIAO, XUE, LIU, DIJIE, DU, WEILI, HE, YING, ZHANG, ZHE, WU, XIUYAN, WANG, JIALING, LIANG, CHUNYAN, ZHANG, LU, LIU, SHU
Formato: Online Artículo Texto
Lenguaje:English
Publicado: D.A. Spandidos 2014
Materias:
Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4214449/
https://www.ncbi.nlm.nih.gov/pubmed/25364456
http://dx.doi.org/10.3892/ol.2014.2558

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4214449/
https://www.ncbi.nlm.nih.gov/pubmed/25364456
http://dx.doi.org/10.3892/ol.2014.2558

Ejemplares similares